New technique could benefit ‘high risk’ heart patients

Cardiologists and cardiac surgeons at King’s College Hospital in London have started a new programme to treat patients with aortic valve stenosis (narrowings of the aortic valve).

King’s staff carried out the first two successful transapical aortic valve replacements in the UK and two percutaneous aortic valve replacements. The trial involves evaluating two options for minimally invasive aortic valve replacement:
·    Percutaneous or transfemoral aortic valve replacement – where a heart valve prosthesis is implanted into the heart by a cardiologist through a leg (femoral) artery.
·    Transapical aortic heart valve replacement  - where a heart valve prosthesis is implanted by a cardiac surgeon using keyhole surgery through the apex of the heart.
 
These “keyhole” surgery techniques could benefit frailer patients considered unsuitable for open heart surgery by avoiding the risks of lengthy open surgery, which could mean thousands more UK patients could receive treatment.

The operations were carried out by a multidisciplinary team of two cardiologists, Dr Martyn Thomas and Dr Phil MacCarthy and two cardiac surgeons, Mr Ahmed El-Gamel and Mr Olaf Wendler.

Mr Wendler, consultant cardiac surgeon and clinical director for cardiology and cardiothoracic surgery at King’s said: “We are very excited by the results of these operations.  All four patients were chosen for these procedures because they were considered ‘high risk’ for open heart surgery.  

“Thanks to these techniques, none of the four needed to be admitted to an intensive care unit after surgery, they all recovered without complications and were ready to be discharged home only a week after surgery. As aortic valve replacement is currently the only treatment option for aortic stenosis, these new minimally-invasive procedures could potentially revolutionise treatment for patients who suffer from this condition.”

Ellen Mason, cardiac nurse at the British Heart Foundation (BHF) said: “We welcome this exciting clinical trial. We hope the findings will lead to these treatments becoming better established and widely available in the future for many more heart patients. The new procedure avoids open heart surgery and several hours under anaesthetic which is good news for many elderly heart patients who are often at higher-risk when undergoing surgery.”

Latest Issues

EBME Expo 2026

Coventry Building Society Arena, Coventry
24th – 25th June 2026

AfPP Regional Conferences: Manchester

INNSiDE by Meliá Manchester
20th June 2026

Endoscopic Anterior Skull Base Surgery: Hands-On Cadaveric Course

Division of Anatomy, University of Leeds
29th- 30th June 2026

BLOCKED – Advanced+ | The Wrightington Regional Anaesthesia Interest Group Cadaveric Course

Wrightington Conference Centre
Tuesday 7th – Wednesday 8th July 2026

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026